Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology.
Rev Esp Cardiol (Engl Ed)
; 73(2): 161-167, 2020 Feb.
Article
em En, Es
| MEDLINE
| ID: mdl-31818706
ABSTRACT
T***he current control of low-density lipoprotein cholesterol among patients with atherosclerotic cardiovascular disease is very low and this is associated with an increase of cardiovascular outcomes. In addition, the latter this happens, the risk will be greater. This is mainly due to an insufficient use of the lipid-lowering therapy currently available. In fact, with current treatments (statins, ezetimibe and PCSK9 inhibitors), the majority of patients in secondary prevention should achieve low-density lipoprotein cholesterol goals. For these reasons, in this manuscript promoted by the Spanish Society of Cardiology we propose three simple and feasible decision-making algorithms that include the majority of clinical scenarios among patients with ischemic heart disease, with the double aim of attaining therapeutic goals in the majority of patients as soon as possible; in secondary prevention the magnitude of the benefit is risk- and time-dependent.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sociedades Médicas
/
Cardiologia
/
Doenças Cardiovasculares
/
Consenso
/
Metabolismo dos Lipídeos
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
País como assunto:
Europa
Idioma:
En
/
Es
Ano de publicação:
2020
Tipo de documento:
Article